Management

Dr Yen Choo
Dr Choo is the founder of Plasticell and has been Chief Executive and Chief Scientist of the company since its inception. He also sits on the UK Stem Cell Steering Committee which regulates national stem cell research and the UK Stem Cell Bank. Prior to his interest in stem cells he was founder and Chief Scientist of Gendaq (1999-2001), a zinc finger engineering company acquired by Sangamo Biosciences and whose technology is now marketed by Sigma-Aldrich. Previously he was a staff scientist at the MRC Laboratory of Molecular Biology, Cambridge (1995-2000), where he pioneered the engineering of protein-DNA interactions using combinatorial methods. Dr Choo holds a PhD in Molecular Biology from the University of Cambridge and for his thesis received the Prize for Young Scientists awarded by GE Healthcare and Science (1996), and the Max Perutz Student Prize awarded by MRC-LMB (1995).

Dennis Saw
Mr Saw is the Chief Financial Officer of Plasticell. He is also founder and principal of Carpathia Global Capital, and previously was co-founder and managing partner of E2 Research LLP (an FSA authorised emerging markets broker) and Orosimo Consulting -- all companies in the financial services sector. He formerly worked at Goldman Sachs where he helped clients execute global securities offerings and complex cross-border M&A. Mr Saw has carried out molecular biology research at the Max Planck Institute for Molecular Genetics, Berlin, and holds a first class degree in life sciences from Imperial College, London.